subscribeSubscribe
price-trendAsk Us
FDA`s ODAC to review accelerated approvals for multiple myeloma, leukemia

FDA`s ODAC to review accelerated approvals for multiple myeloma, leukemia
Z. Brennan ENDPTS
24 Sep 2021
Share Share
Secura Bio Announces New Data Regarding the Combination of FARYDAK®

Secura Bio Announces New Data Regarding the Combination of FARYDAK®
PRNEWSWIRE
02 Feb 2021
Share Share
Secura Bio Acquires Global Rights To Farydak®

Secura Bio Acquires Global Rights To Farydak®
PR NEWSWIRE
12 Mar 2019
Share Share
J&J gets CHMP backing for broader Darzalex use

J&J gets CHMP backing for broader Darzalex use
Phil Taylor PMLIVE
27 Feb 2017
Share Share
What Puts a New Drug Launch in Line for Victory? Ask Gilead, Biogen and J&J

What Puts a New Drug Launch in Line for Victory? Ask Gilead, Biogen and J&J
Eric Sagonowsky FIERCE PHARMA
18 Nov 2016
Share Share
Independent group finds multiple myeloma drugs too costly in U.S

Independent group finds multiple myeloma drugs too costly in U.S
Deena Beasley REUTERS
07 May 2016
Share Share
Empliciti on track for European approval in multiple myeloma

Empliciti on track for European approval in multiple myeloma
Phil Taylor PM LIVE
03 Feb 2016
Share Share
NHS cancer patients gain access to four new therapies

NHS cancer patients gain access to four new therapies
Selina McKee PHARMATIMES
27 Jan 2016
Share Share
Ash Stevens to make API for Takeda`s new oral blood cancer drug

Ash Stevens to make API for Takeda`s new oral blood cancer drug
Gareth MacDonald IN-PHARMA TECHNOLOGIST
24 Nov 2015
Share Share
Takeda`s `breakthrough` Velcade heir wins early FDA approval in myeloma

Takeda`s `breakthrough` Velcade heir wins early FDA approval in myeloma
Damian Garde FIERCE BIOTECH
20 Nov 2015
Share Share